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Number One Suspect in
Polyglutamine Diseases
Polyglutamine expansion diseases are triggered by the accumulation of toxic
proteins. A new study reports that RNAmolecules containing long CAG repeats
can also be toxic to neurons and may play a significant role in pathogenesis.Serge Birman
Trinucleotide expansion diseases are
known to be of two varieties — those
caused by toxic activity of a mutant
protein and those triggered by aberrant
RNAmolecules containing long repeats
in untranslated regions (UTRs)
[1]. Inherited neurodegenerative
disorders, such as Huntington’s and
Kennedy’s diseases, and several forms
of spinocerebellar ataxia (SCA) are
caused by the expansion of a CAG
repeat in translated exons, leading to
expression of mutant proteins
containing abnormally long
polyglutamine domains. Until recently,
it was believed that accumulation of the
mutant protein was solely responsible
for the pathogenesis [2]. In a recent
paper [3], Bonini and colleagues
describe that RNA toxicity is involved
in polyglutamine expansion diseases,
thus potentially unifying pathogenic
mechanisms generated by non-coding
and coding trinucleotide repeats.
The initial finding of these authors
that suggested a role of RNA in
pathogenesis was the identification of
Muscleblind, an RNA-binding protein
and a splicing factor [4], as amodifier of
the eye phenotype in a Drosophila
model of Machado-Joseph disease or
SCA3 [5]. The protein product of the
mutant ataxin-3 gene, which has been
implicated in SCA3, contains an
expanded polyglutamine tract
encoded by around 70 CAG repeats
in its carboxy-terminal domain [6,7].
Co-expression of Drosophila
Muscleblind (the MblA isoform) or
human homologue MBNL1 in the
Drosophila eye markedly acceleratedthe depigmentation and photoreceptor
degeneration that is triggered by
pathogenic segments of mutant
ataxin-3 [3]. Muscleblind also
enhanced eye defects induced by a
segment of the Huntington’s disease
protein but not those mediated by
the tau protein, which lacks a
polyglutamine domain. Co-expression
of Muscleblind also accelerated the
death of flies expressing the
pathogenic SCA3 protein in all neurons.
Conversely, the lifespan of these flies
was significantly prolonged in a genetic
background heterozygous for a null
muscleblind allele.
In contrast to the previous results, an
altered form of MBNL1 that cannot
bind well to RNA did not significantly
enhance the eye phenotype triggered
by mutant ataxin-3 [3]. The
Muscleblind protein is known to bind
to CUG or CCUG repeat RNAs, which
are the toxic agents of myotonic
dystrophy type 1 and 2, respectively.
The pathogenic mechanism in these
diseases involves the sequestration of
Muscleblind and other splicing factors
by the mutant RNA in nuclear foci,
thus disturbing the normal patterns
of splicing in various cell types
[4,8,9]. Formation of double-stranded
hairpin structures is required for the
association of the CUG repeat RNA
with Muscleblind. But MBNL1 was also
shown to bind CAG repeat RNA, which
forms a similar stable double-stranded
structure, both in vitro and in cultured
cells [10,11] (Figure 1). Interestingly,
in living flies, overexpression of
Muscleblind increased the level of CAG
repeat RNA as well as polyglutamine
peptides [3], suggesting that thisprotein increases deleterious
phenotypes by stabilizing the
pathogenic agent, whether it be
RNA or protein.
To determine the exact nature of the
toxic agent in their model, Bonini and
colleagues [3] engineered a mutant
ataxin-3 segment in which the
continuous CAG repeat was replaced
by an interrupted CAACAG repeat.
Both repeats were expected to be
translated into the same polyglutamine
tract. In spite of similar levels of
expressed protein, the eye phenotypes
observed with each construct were
strikingly different, being much
alleviated with the interrupted repeat.
Similarly, the lifespan of flies
expressing the mutant ataxin-3 in all
neurons at the same level was
prolonged, but not completely rescued,
when the CAG repeat was replaced by
the CAACAG repeat. Interestingly,
protein inclusions were found at similar
abundance in both types of transgenic
flies, indicating that intensity of the
deleterious phenotypes does not
correlate with the number of inclusions.
The interrupted CAACAG repeat RNA
is not expected to form stable
double-stranded hairpin structures.
Accordingly, co-expression of
Muscleblind only slightly enhanced
the eye phenotype observed with the
interrupted construct and did not
increase the level of this particular
RNA.
Therefore, part of the toxicity in SCA3
could be due to the CAG repeat RNA.
To determine whether RNA can be
toxic in the absence of mutant protein,
the authors expressed untranslated
expanded CAG repeats inserted in the
30-UTR of the DsRed gene, an ectopic
fluorescent marker. Targeted
expression of untranslated CAG repeat
RNA in neurons induced progressive
locomotor deficits, a reduction in
lifespan and brain degeneration in adult
flies. Expression in the eye did not
modify the external morphology of this
organ but resulted in degeneration of
the internal retina. Therefore,
untranslated CAG repeat RNA appears




































































































































































































































Figure 1. Both mutant RNA and protein contribute to neurodegeneration in polyglutamine
expansion diseases.
Polyglutamine diseases originate from an abnormally expanded CAG repeat in genomic DNA
of specific genes. The encoded mRNA and proteins include an expanded CAG repeat segment
and a polyglutamine domain, respectively. Proteins with a long polyglutamine domain or pure
polyglutamine peptides are known to be toxic. The recent study suggests that untranslated
CAG repeat RNA is also pathogenic to neurons [3]. In SCA8 and possibly other related dis-
eases, bidirectional transcription of the mutant locus yields an untranslated and toxic CUG re-
peat [16]. Both the CAG and CUG repeats form double-stranded hairpins that associate with
one or several molecules of the RNA-binding protein Muscleblind, which regulates trinucleo-
tide repeat RNA toxicity and could play a significant role in pathogenesis of polyglutamine dis-
eases. (Annular structures of the polyglutamine peptide and Muscleblind protein are inferred
from [18] and [11], respectively.)primarily detrimental to neurons in this
model. This may in part explain the
discrepancy with previously published
work that ruled out a toxic role of CAG
repeat RNA based on the analysis of
the external appearance of the
Drosophila eye [12]. The CAG repeat
RNA accumulated in nuclear foci,
which were smaller but comparable to
foci formed by CUG repeat RNA in flies
or in myotonic dystrophy patients.
Expression of Muscleblind enhanced
both the stability and neuronal toxicity
of the CAG repeat RNA. As expected,
interrupted CAACAG RNAs of similar
lengths proved not to be toxic in these
conditions. Again this may solve the
apparent contradiction with another
recently published paper that argued
against direct toxicity of repeat RNA
[13]. In this work, the RNA molecules
expressed were large concatemers of
triplets interrupted every 20 repeats,
a structure that may well interfere
with toxicity.
Evidence that trinucleotide repeat
RNA can induce neurodegeneration
was previously demonstrated in
a Drosophila model of fragile
X-associated tremor/ataxia syndrome
(FXTAS) [14]. This disease is caused bythe expansion of between 55 and 200
CGGs in the 50-UTR of the FMR1 gene,
leading to neuronal degeneration in
the cerebellum, brain atrophy and
parkinsonism. Expression of an
untranslated CGG RNA of 90 repeats
disrupted eyemorphology and induced
lethality when targeted to all neurons.
Here again the effect of untranslated
RNA appeared to be neuron specific,
as with the CAG repeat RNA. Two
findings were quite unexpected in this
model. First, untranslated CGG repeat
RNA promoted the appearance of
nuclear inclusions containing ubiquitin
and Hsp70, and therefore quite similar
to the inclusions formed in the
presence of pathogenic polyglutamine
peptides [1,2]. Second, the
RNA-mediated neurodegeneration
could be suppressed by
overexpression of the chaperone
protein Hsp70, as is the case
in polyglutamine disease models
[15]. This suggested that the toxic RNA
could trigger protein misfolding and
aggregation. Although this is not
reported in the present paper by Bonini
and colleagues [3], it would be very
interesting to look for the presence of
nuclear inclusions and protection byHsp70 when untranslated CAG repeat
RNAs are expressed in Drosophila.
Thus, these data seem to bridge the
gap between disorders mediated by
polyglutamine peptides and
trinucleotide repeat RNA (Figure 1). In
one neurodegenerative disease, SCA8,
the two toxic agents have been
strikingly reported to be co-expressed
by bidirectional transcription of a single
expansion mutation, yielding on one
side an untranslated CUG repeat
transcript and on the other side a short
protein containing almost pure
polyglutamine [16]. In light of the recent
results of Bonini and colleagues
[3], one could now add the CAG repeat
transcript as a potential third toxic
agent in this disease. The development
of a Drosophila model of SCA8, based
on the expression of untranslated
pathogenic CUG repeat RNA, also led
to the identification of Muscleblind
as a modifier of eye degeneration
[17]. Heterozygous loss-of-function
mutations ofmuscleblind enhanced the
eye phenotype induced by the CUG
repeat RNA. In the SCA3 model, both
overexpression and heterozygous
mutations of muscleblind increased
photoreceptor cell loss, whereas these
same mutations rescued neuronal
dysfunction [3]. This indicates that
according to the cell context, the
RNA-binding protein can enhance or
decrease deleterious effects of the
pathogenic RNAs and proteins.
Therefore, Muscleblind is likely to play
a central and complex role in various
trinucleotide repeat neurodegenerative
diseases.
In conclusion, this recent work
brilliantly illustrates the usefulness of
model organisms, and particularly the
Drosophila models introduced 10 years
ago, to unravel the molecular
mechanisms of neurodegenerative
diseases. From these efforts, it now
appears that neurodegenerative
diseases caused by trinucleotide
expansion may share similar basic
mechanisms of pathogenesis involving
combined toxic effects of expanded
repeat RNA and protein.
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Neurons are highly polarized cells, with
neurotransmitters from neighboring
axons binding to receptors on
dendrites, thus allowing for directional
signaling. Disruption of this
polarization by severing the axon
eliminates the ability of a neuron to
function. In young, immature neurons,
restoration of polarity can occur by
transforming a dendrite into a new axon
[1]. An important, clinically relevant,
question is whether this can also occur
in older, mature neurons. In a new
study reported in a recent issue of
Current Biology, Gomis-Ru¨th et al. [2]
show that it is possible for neurons that
have already grown to maturity and
established functional connections to
regenerate their axons. This ability
seems to stem from the neuron’s
capacity to continually remodel its
microtubule cytoskeleton, despite the
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ability for the microtubules to be
remodeled has been suggested before
but has not yet been shown in mature
neurons [3].
The cytoskeletal structure of neurons
differs in axons and dendrites in
several ways. Axons contain the
microtubule-associated protein (MAP)
tau while dendrites contain MAP2.
The microtubules are also oriented
differently in axons and dendrites,
with microtubules being mostly
unidirectional in the axon and
bi-directional in the dendrite. In
addition, axons contain more stable
microtubules than do dendrites.
Young, migrating neurons go through
phases in which they aremultipolar and
eventually settle into a unipolar state
before finishing their migration [4]. This
process of polarization would have to
involve the distinction of the axon from
the many nascent extensions resulting
in orientation and stability changes in
the microtubule cytoskeleton. It was
previously unknown if these changes
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DOI: 10.1016/j.cub.2008.06.023In this new study, Gomis-Ru¨th et al.
[2] show that mature neurons with
established connections form new
axons when the original axon is cut
and that microtubule stability plays
an important role in this process.
Significantly, the authors show that
new axon formation occurs both in vitro
and ex vivo [2]. The authors found
that axotomy closer to the cell body
results in the transformation of a
dendrite into a new axon. The identity
of the new axons was confirmed by
a number of features, including the
formation of functional synapses [2].
Distal axotomy caused regrowth of
the original axon (Figure 1).
These results raise the question of
how transformation of a dendrite into
an axon occurs. It was recently shown
that microtubule stabilization helps
specify initial neuronal polarization [5].
To understand whether microtubule
stability plays a role in axonal
determination in mature neurons,
Gomis-Ru¨th et al. [2] stabilized the
microtubules of neurons in culture with
taxol. Surprisingly, they found that this
treatment causes formation of multiple
axons. The study demonstrates for
the first time that microtubule stability
is sufficient to cause a mature neuron
to form multiple axons. The
transformation and growth of dendrites
into axons continues after taxol has
been washed out, suggesting that the
initial stabilization of microtubules may
be the critical signal for axonal growth.
